Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Dasatinib Tablets in multiple strengths: 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. This is a generic version of Sprycel Tablets, which is used for treating Philadelphia chromosome-positive (Ph+) chronic myeloid …